Boston-based medical device company AVS recently raised $20 million in Series B funding to bring its arterial disease treatment closer to FDA clearance. The system that AVS is developing uses pressure waves to shatter calcium that has built up in arteries.
Shockwave Medical is harnessing sound waves to break up calcium in blocked arteries and using them with the familiar angioplasty balloon catheter to treat patients with peripheral artery disease.
CEO shares how Ambience can help reduce administrative burden.
Shockwave Medical just got $40M for its technology that breaks up plaques in vascular disease - much like the lithotripsy used to treat kidney stones.